Top Markets
#1 Prom Prom +32.52%
#2 QuantixAI QuantixAI +31.15%
#3 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +27.84%
#4 MowCat MowCat +27.65%
#5 Tutorial Tutorial +25.56%
#6 UnifAI Network UnifAI Network +23.38%
#7 Pons Pons +17.13%
#8 Versatize Coin Versatize Coin +16.66%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +13.44%
#10 Derive Derive +12.03%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
Rank in Stocks #20646
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$22.66
Market Cap
$125.37M
Change (1 day)
0.63%
Change (1 year)
-21.46%
Country
PL
Trade Bioceltix S.a. (BCX)

Category

Healthcare
Stock price history for Bioceltix S.a. (BCX)
Highest end of day price: $22.80 on 2026-08-01

Lowest end of day price: $8.58 on 2021-11-01
Stock price history of Bioceltix S.a. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 5.94%
2025 17.75%
2024 -9.56%
2023 146.80%
2022 -15.69%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.27 -15.19%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $763.69 8.06%
CH